A new non-invasive blood test for non-alcohol steato hepatitis (NASH) and liver fibrosis could become an invaluable tool in early diagnosis and monitoring of the conditions without the need for an invasive liver biopsy. The liquid biopsy, which predicts the staging of...
This translation tool uses automatic translation. Please talk to your doctor before making any changes to your treatment or daily life. Some text that is part of charts or diagrams may not be translated. The information on this website is about the UK health system (NHS). We hope having translated information is helpful for you.